case discussion: how do drugs/patients impact need and type of monitoring | laura waters, md, frcp
Published 3 years ago • 27 plays • Length 19:10Download video MP4
Download video MP3
Similar videos
-
16:14
case discussion: how do drugs/patients impact need and type of monitoring | marta boffito
-
8:23
con standpoint - laura waters, md, frcp
-
16:10
managing toxicity in the complex hiv patient | laura waters md, frcp
-
28:57
arv toxicity and their management (including weight gain) - laura waters,md
-
31:34
long acting arv for treatment and prevention - clinical considerations | laura waters, md, frcp
-
17:41
my hiv medication/side effects
-
43:43
what are hiv criminalization laws? with robert suttle
-
55:11
hdsi industry seminar: foundation medicine, leah comment
-
28:15
missed the prep opportunity? | laura waters, md, frcp
-
16:56
resistance considerations when choosing optimal treatment - laura waters, md, frcp
-
19:11
impact on women’s health and weight gain | laura waters, md
-
5:24
people first charter - laura waters
-
2:15
preview of update on insti toxicity | laura waters, md, frcp
-
12:17
challenges in routine hiv care in the covid 19 era - laura waters, md, frcp
-
24:01
state of the art: insti toxicities and their management | laura waters, md, frcp
-
27:31
discussion: current oral regimens versus long-acting injectables - chen seong wong & laura waters
-
16:36
clinical review: new rt inhibitors – doravirine - laura waters
-
22:14
laura waters | european meeting on hiv & hepatitis 2023
-
25:18
obesity and hiv treatment: knowns and unknowns - laura waters
-
32:29
innovations in long-acting new arvs and drug formulations (...) - keerti gedela, frcp, msc, dtm&h
-
24:15
laura waters | european hiv clinical forum
-
20:46
rio hiv clinical forum 2020 | laura waters - comparative side effects integrase inhibitors